DermaLux Powder
Natural health product licensed in Canada
- Other names
- DermaLux, Opulence
- Licence holder
- Revelox Distribution
- NPN or DIN-HM
- 80106773
- Status
- Active licence
- Licence date
- 8 December 2020
- Revision date
- 5 July 2021
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Collagène hydrolysé | 6,000 mg | Not calculated |
| Acide hyaluronique Source : Streptococcus equi - capsule extracellulaire bactérienne | 40 mg | Not calculated |
| Zinc Source : Gluconate de zinc | 20 mg | Not calculated |
| Silicium Source : Dioxyde de silicium | 25 mg | Not calculated |
| 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl Source : Rhodobacter sphaeroides - Whole | 30 mg | Not calculated |
| Vitamine C Source : Acide ascorbique | 200 mg | Not calculated |
Non-medicinal ingredients
Saveur, Extrait de fruit de monk
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 packet | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to reduce joint pain associated with osteoarthritis. A factor in the maintenance of good health. Helps to maintain healthy hair, nails and/or skin. Helps to maintain healthy skin.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80106773
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging